Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Neisseria meningitidis group C capsular polysaccharide protein conjugate; Neisseria meningitidis group W135 capsular polysaccharide protein conjugate; Neisseria meningitidis group Y capsular polysaccharide protein conjugate; Neisseria meningitidis group A capsular polysaccharide protein conjugate
GlaxoSmithKline UK Ltd
J07AH04
Neisseria meningitidis group C capsular polysaccharide protein conjugate; Neisseria meningitidis group W135 capsular polysaccharide protein conjugate; Neisseria meningitidis group Y capsular polysaccharide protein conjugate; Neisseria meningitidis group A capsular polysaccharide protein conjugate
Powder and solvent for solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 14040000; GTIN: 5000483111571